MEDICAL TECHNOLOGIES,
DIGITAL TOOLS AND
ARTIFICIAL INTELLIGENCE

Outcome of emergency funding action for coronavirus SARS-CoV-2 outbreak
for SC1-PHE-CORONAVIRUS-2020-2B call


The resluts for the second request for expressions of interest for innovative and rapid health-related approaches to respond to COVID-19 launched by the European Commission have been published.
€ 55.2 million

Budget
13 projects

Short-listed projects
2 years

Maximum project duration
Coordinating institutions for the MEDICAL TECHNOLOGIES, DIGITAL TOOLS AND ARTIFICIAL INTELLIGENCE projects are: Politecnico di Milano (IT), Bat-Call Ltd (IL), Icometrix NV (BE), Institut de Ciències Fotòniques - ICFO (ES), Palliare Ltd (IE), Villinger GmbH (AT), UNINOVA-Instituto de Desenvolvimento de Novas Tecnologias (PT), Johann Wolfgang GoetheUniversität Frankfurt am Main (DE), F6S Network Ltd (IE), Laboratório Ibérico Internacional de Nanotecnologia - INL (PT), Idryma Technologias Kai Erevnas (EL), Luxembourg Institute of Health (LU), Université de Lille (FR).
Expected EU contribution per proposal
Accordingly to the call's text, the proposed projects will encompass a combination of tools and technologies, such as: microelectronics, micro/nano/cyber-physical systems; bio-functionalized chips and biosensor arrays; bio-photonics; graphene or related materials (GRM); data, AI and robotics; pathogen detection technologies; e-health, telemedicine and digital solutions.

It is expected that EU contribution per proposal will be between EUR 2 and 5 million and if project forsees the financial support to third parties (typically in the order of EUR 20.000 to 100.000 per third party), up to EUR 10 million.
Expected impact from the projects
  • To contribute to the public health preparedness and response in the context of the ongoing epidemic of COVID-19 and to ensure the availability of critical technologies and tools.
  • To contribute to the acceptability, adoption, appropriateness, feasibility, fidelity, implementation cost, coverage, and sustainability of diagnosis and clinical management of patients and survivors of COVID-19.
  • To contribute to proposing recommendations for changes that would allow a fast recovery and a better preparedness, including in the health care systems, for future health emergencies.
  • To accelerate the deployment and market uptake of mature health technologies for the prevention and optimised treatment of the COVID-19 disease, by delivering results within 3-24 months to end-users at scale.

Evaluation results for the call in fugures
Number of proposals submitted: 221
Number of inadmissible proposals: 6
Number of ineligible proposals: 4
Number of above-threshold proposals: 13
Total budget requested for above-threshold proposals: EUR 348.181.075, 64
Available budget: EUR 56.000.000
Reference